Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Endocrinology and Metabolic Disorders

Hunter Syndrome Market experiences a positive p...

The Hunter Syndrome Market is expected to grow with CAGR of 7.5% in the coming years in the 7MM. Occurring in approximately 1 in 100,000 to 1 in 170,000 male births, Hunter Syndrome, is an X-linked...

May 22, 2020

recent-pharma-news
AbbVie, Sofinnova back; Gilead, Kite ink; Biogen aims filing; Reversing diabetes

AbbVie, Sofinnova back USD 38 Million for Nitrome Biosciences Nitrome Biosciences contemplates treating Parkinson's disease and diabetes by targeting a new class of enzymes. The pharma raised USD 38 million from the Sofinnova Partners and AbbVie Ventures. The San Francisco-based biotech is focusing at a famil...

Find More
pharma news
Niacin fights Glioblastoma, iTeos nets $125M, Pandion reels in $80M, Brii, Chinese partner, FDA to speed up COVID-19 therapies

Niacin might help in combating Glioblastoma  Glioblastomas are difficult to treat in part as the brain’s immune cells are stifled and unable to attack against tumors. A research team of the University of Calgary in Canada revealed that a common vitamin might help resolve the issue. The researchers presen...

Find More
Bioelectronic Medicine
Bioelectronic Medicine: Applications and Future Prospects

Healthcare industry during the past few decades has witnessed phenomenal growth and improvement due to technological advancement and innovation. The hospital management, medical devices & equipment, pharmaceutical products, and surgical procedures all have gone under tremendous up-gradation and improvement.&nbs...

Find More

More Views & Analysis

Dubai healthcare
Dubai: A leading and exciting pharma hotspot

The dream of the UAE government to place its capital city among the best cities in the world has led to the introduction of ‘Dubai plan 2021’, focused on transforming into a smart city through an investment of more than USD 7 Billion. Dubai’s smart city strategy includes over 100 initiatives, which aims at fosterin...

Find More

Healthcare scenario in MENA region
Booming Healthcare sector in MENA: Lucrative opportunity for Global pharma players

The Middle-East and North-Africa region (MENA), which encompasses some of the world’s wealthiest economies, extends unparalleled opportunities to multinational corporations with expertise in medical devices. There is a conspicuous disparity in the economic prowess across the countries, but most of them have shown r...

Find More

Digital therapeutics
Potential of Digital therapeutics and increasing CVDs

The 21st century has been a remarkable century for humankind, as a lot of innovation, research and development has taken place in the field of healthcare, due to which we have been able to increase the overall lifespan of the human beings.  However, the central question is, are we able to increase the healt...

Find More

thyroid eye disease
Thyroid awareness month

January month is the Thyroid awareness month, and it is a great way to comprehend the treatment, prevention, and causes of thyroid-related diseases and cancer for the people who are affected.One of them is Thyroid eye disease, which is also known as Graves' Orbitopathy or Ophthalmopathy that is an autoimmune disea...

Find More

Pharma News
Tepezza receives approval; a new way to treat Alzheimer’s

Horizon Therapeutics has become the first company to receive the regulatory approval of its drug Tepezza for the cure of Thyroid Eye Tepezza (teprotumumab-trbw) is the first-ever treatment approved for thyroid eye is a progressive autoimmune disorder hampering the ability of vision. The drug was approved under P...

Find More

Pharma News
Cumberland’s methotrexate product gets approval in the US; Baker Brothers purchases stake in Kodiak’s KSI-301; Sanofi offloads Seprafilm unit to Baxter

Cumberland Pharmaceuticals has recently received approval from the US FDA for its RediTrex injection for the treatment of rheumatoid arthritis. Cumberland pharmaceuticals pharma company focusing on acquiring and commercializing prescription products has gained access to the injection from Nordic Group two years...

Find More

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Find More

Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the .....

Find More

Postoperative Pain is the pain that an individual experiences after a major operation or surgical pr.....

Find More

Crohn's disease (CD) is a type of inflammatory bowel disease (IBD). In this condition, the immune sy.....

Find More

Myocardial infarction (MI), colloquially known as “heart attack” is caused by decreased or compl.....

Find More

Retinitis pigmentosa is a gradual deterioration of the ability of eyes to see. The defect in the eye.....

Find More